257
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin

&
Pages 4749-4767 | Published online: 29 Aug 2012

References

  • LuJMWangXMarin-MullerCCurrent advances in research and clinical applications of PLGA-based nanotechnologyExpert Rev Mol Diagn2009932534119435455
  • SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine2010666267120230912
  • JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials2000212475249011055295
  • LimTYPohCKWangWPoly (lactic-co-glycolic acid) as a controlled release delivery deviceJ Mater Sci Mater Med2009201669167519283453
  • DuLMeiXWangCLiXZhangFJinYIn-vitro/in-vivo studies of the biodegradable poly-(D,L-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatmentAnticancer Drugs20112226227221360849
  • GrabruckerAMGarnerCCBoeckersTMDevelopment of novel Zn loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidencesPLoS One20116e1785121448455
  • RanganathSHFuYArifinDYThe use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in miceBiomaterials2010315199520720350766
  • AvgoustakisKPegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug deliveryCurr Drug Deliv2004132133316305394
  • BetancourtTByrneJDSunaryoNPEGylation strategies for active targeting of PLA/PLGA nanoparticlesJ Biomed Mater Res A20099126327618980197
  • GrefRLuckMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces20001830131310915952
  • DingHYongKTRoyIBioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriersNanotechnology20112216510121393821
  • DharSKolishettiNLippardSJFarokhzadOCTargeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivoProc Natl Acad Sci U S A20111081850185521233423
  • MoghimiSMHunterACMurrayJCLong-circulating and target-specific nanoparticles: theory to practicePharmacol Rev20015328331811356986
  • AvgoustakisKBeletsiAPanagiZEffect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticlesInt J Pharm200325911512712787641
  • SledgeGWMillerKDJrExploiting the hallmarks of cancer: the future conquest of breast cancerEur J Cancer2003391668167512888360
  • TeicherBAMolecular targets and cancer therapeutics: discovery, development and clinical validationDrug Resist Updat20003677311498368
  • MaedaHTumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospectsBioconjug Chem20102179780220397686
  • MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000627128410699287
  • MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SmancsCancer Res198646638763922946403
  • NakanishiTFukushimaSOkamotoKDevelopment of the polymer micelle carrier system for doxorubicinJ Control Release20017429530211489509
  • TobioMGrefRSanchezALangerRAlonsoMJStealth PLA-PEG nanoparticles as protein carriers for nasal administrationPharm Res1998152702759523314
  • ZhaoHYungLYSelectivity of folate conjugated polymer micelles against different tumor cellsInt J Pharm200834925626817850996
  • FarokhzadOCJonSKhademhosseiniATranTNLavanDALangerRNanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cellsCancer Res2004647668767215520166
  • ChengJTeplyBASherifiIFormulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryBiomaterials20072886987617055572
  • FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A20061036315632016606824
  • EsmaeiliFGhahremaniMHOstadSNFolate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugateJ Drug Target20081641542318569286
  • LeeHHuMReillyRMAllenCApoptotic epidermal growth factor (EGF)-conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapyMol Pharm2007476978117867644
  • AcharyaSDilnawazFSahooSKTargeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapyBiomaterials2009305737575019631377
  • ZhangNChittasuphoCDuangratCSiahaanTJBerklandCPLGA nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1Bioconjug Chem20081914515217997512
  • MoriyaTKanomataNKozukaYMolecular morphological approach to the pathological study of development and advancement of human breast cancerMed Mol Morphol201043677320683691
  • AlshenawyHAImmunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deathsAnn Diagn Pathol20101438739521074685
  • SimonettiSMolinaMAQueraltCDetection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancerTransl Med20108135
  • PalSKFiglinRAReckampKTargeted therapies for non-small cell lung cancer: an evolving landscapeMol Cancer Ther201091931194420571071
  • KoloninMGBoverLSunJLigand-directed surface profiling of human cancer cells with combinatorial peptide librariesCancer Res200666344016397212
  • HarrisRCChungECoffeyRJEGF receptor ligandsExp Cell Res200328421312648462
  • TarasevichBJGutowskaALiXSJeongBMThe effect of polymer composition on the gelation behavior of PLGA-g-PEG biodegradable thermoreversible gelsJ Biomed Mater Res A20098924825418464255
  • GhahremankhaniAADorkooshFDinarvandRPLGA-PEG-PLGA tri-block copolymers as in situ gel-forming peptide delivery system: effect of formulation properties on peptide releasePharm Dev Technol200813495518300099
  • GoddardEDTurroNJKuoPLAnanthapadmanabhanKPFluorescence probes for critical micelle concentration determinationLangmuir1985135235521370917
  • LinWJChenMHSynthesis of multifunctional chitosan with galactose as a targeting ligand for glycoprotein receptorCarbohydr Polym200767474480
  • YinYChenDQiaoMWeiXHuHLectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistributionJ Control Release2007123273817728000
  • DavaranSRashidiMRPourabbasBDadashzadehMHaghshenasNMAdriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterizationInt J Nanomedicine2006153553917722284
  • CiapettiGCenniEPratelliLPizzoferratoAIn vitro evaluation of cell/biomaterial interaction by MTT assayBiomaterials1993143593648507779
  • Campos-LaraMMendoza-EspinozaJACytotoxic evaluation of fluvastatin and rosuvastatin and effect of fluvastatin in the HeLa cell cycleAfr J Pharm Pharmacol20115322326
  • ChittasuphoCXieSXBaoumAYakovlevaTSiahaanTJBerklandCJICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cellsEur J Pharm Sci20093714115019429421
  • JinCQianNZhaoWImproved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab’)(2) for hepatocellular carcinomaBiomacromolecules2010112422243120831277
  • YadavAKMishraPMishraAKMishraPJainSAgrawalGPDevelopment and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicinNanomedicine2007324625718068091
  • BuwaldaSJDijkstraPJCalucciLForteCFeijenJInfluence of amide versus ester linkages on the properties of eight-armed PEG-PLA star block copolymer hydrogelsBiomacromolecules20101122423219938809
  • LeeESOhKTKimDYounYSBaeYHTumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine)J Control Release2007123192617826863
  • KimSYShinIGLeeYMChoCSSungYKMethoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behavioursJ Control Release19985113229685900
  • IoeleGCioneERisoliAGenchiGRagnoGAccelerated photostability study of tretinoin and isotretinoin in liposome formulationsInt J Pharm200529325126015778063
  • van VlerkenLEDuanZLittleSRSeidenMVAmijiMMBiodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer modelMol Pharm2008551652618616278
  • ZangeRLiYKisselTBiocompatibility testing of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture modelsJ Control Release1998562492589801448
  • SinghAWilczynskiAHolderJRIncorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D 1H NMRJ Med Chem2011541379139021306168
  • MilaneLDuanZAmijiMDevelopment of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cellsMol Pharm2011818520320942457
  • YousefpourPAtyabiFVasheghani-FarahaniEMovahediAADinarvandRTargeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumabInt J Nanomedicine201161977199021976974
  • KhoeeSRahmatolahzadehRSynthesis and characterization of pH-responsive and folated nanoparticles based on self-assembled brush-like PLGA/PEG/AEMA copolymer with targeted cancer therapy properties: a comprehensive kinetic studyEur J Med Chem20125041642722397922
  • GilliesERFréchetJMpH-responsive copolymer assemblies for controlled release of doxorubicinBioconjug Chem20051636136815769090
  • UngerFWittmarMMorellFKisselTBranched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co- vinyl alcohol]-graft-poly (D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviourBiomaterials2008292007201418262641
  • XueHYWongHLTailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitizationBiomaterials2011322662267221236485
  • ManchunSDassCRSriamornsakPTargeted therapy for cancer using pH-responsive nanocarrier systemsLife Sci20129038138722326503
  • HanHDLeeAHwangTEnhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomesJ Control Release200712016116817524514